Use of Pharmacogenetics in Bioequivalence Studies to Reduce Sample Size: An Example With Mirtazapine and CYP2D6
Pharmacogenomics Journal- United Kingdom
doi 10.1038/tpj.2012.29
Full Text
Abstract
Available in
Date
June 26, 2012
Authors
Publisher
Springer Science and Business Media LLC